Exploring the Role of Amitriptyline in Modulating Gag Reflex Sensitivity
Open Access
- 15 October 2025
- journal article
- Published by Brieflands in Iranian Journal of Pharmaceutical Research
- Vol. 24 (1) , e160912
Abstract
Background: The gag reflex serves as an essential protective airway mechanism but can significantly interfere with dental care, affecting up to 44% of patients and leading to treatment avoidance in severe cases. Objectives: To evaluate the effect of the topical application of an amitriptyline solution on reducing the gag reflex intensity, measured by the Gag Trigger Point Index (GTPI). Methods: In this randomized single-blind clinical trial, 48 participants with a GTPI score higher than two were divided into amitriptyline (treatment) and lidocaine (control) groups. In the amitriptyline group, 75 mg of amitriptyline tablets were dissolved in 5 milliliters of distilled water (15 mg/mL) and gargled for one minute by the participants. Then, the GTPI was examined after 10 minutes. In the lidocaine group, four puffs of 10% lidocaine spray were applied to the target areas of the oral mucosa, and the GTPI was measured five minutes later. The taste and smell of both medications were assessed using a self-report questionnaire to measure patient satisfaction. The data were analyzed using SPSS version 22. Results: In both the lidocaine and amitriptyline groups, GTPI levels demonstrated significant decreases. The lidocaine group showed a change from 4.46 to 2.42 (P < 0.001), and the amitriptyline group showed a change from 4.04 to 1.29 (P < 0.001). The reflex change rate was -2.75 in the amitriptyline group and -2.04 in the lidocaine group. When comparing the groups, no statistically significant differences were observed in the extent of gag reflex reduction or in participants’ perception of taste and smell (P > 0.05). Conclusions: Amitriptyline can be considered a potential alternative to lidocaine spray in gag reflex management, particularly in lidocaine-intolerant patients. Further studies are needed to confirm long-term safety and determine the local versus systemic pharmacological effects.Keywords
This publication has 39 references indexed in Scilit:
- Impact of sedative and appetite-increasing properties on the apparent antidepressant efficacy of mirtazapine, selective serotonin reuptake inhibitors and amitriptyline: an item-based, patient-level meta-analysiseClinicalMedicine, 2024
- Efficacy and safety of ibuprofen gargle for postoperative pain after mandibular third molar extraction: A phase II, placebo‐controlled, double‐blind, randomized crossover trialClinical and Experimental Dental Research, 2023
- Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictorsJournal of Neurology, 2022
- Is laser acupuncture effective in controlling gag reflex while taking dental impressions? A randomized double-blinded sham-controlled clinical trialJournal of Evidence-Based Dental Practice, 2022
- Impact of intravenous and topical lidocaine on clinical outcomes in patients receiving propofol for gastrointestinal endoscopic procedures: a meta-analysis of randomised controlled trialsBritish Journal of Anaesthesia, 2022
- Insufficient evidence regarding the effects of any intervention to reduce the risk of gagging during dental treatment to conclude that any intervention is beneficialThe Journal of the American Dental Association, 2020
- Cranial Nerve Imaging and PathologyNeurologic Clinics, 2020
- Management of gag reflex for patients undergoing dental treatmentCochrane Database of Systematic Reviews, 2019
- Managing cyclic vomiting syndrome in children: beyond the guidelinesEuropean Journal of Pediatrics, 2018
- Comparative study between benzydamine hydrochloride gel, lidocaine 5% gel and lidocaine 10% spray on endotracheal tube cuff as regards postoperative sore throatBrazilian Journal of Anesthesiology (English Edition), 2016